FDA Regulations Expert Witness

An FDA regulations expert witness evaluates whether drugs, medical devices, biologics, food products, cosmetics, or other regulated products complied with applicable FDA requirements.

These experts may be retained in product liability, pharmaceutical litigation, medical device disputes, labeling cases, clinical trial matters, recalls, enforcement actions, manufacturing disputes, and cases involving alleged failures to follow federal regulatory requirements.

Blackstorm Experts helps attorneys identify former FDA professionals, regulatory affairs executives, pharmaceutical scientists, quality-system specialists, and other experts whose experience matches the regulated product and issue involved in the case.

What Does an FDA Regulations Expert Witness Evaluate?

An FDA regulations expert may review regulatory submissions, correspondence with the agency, product labeling, clinical trial documentation, manufacturing records, quality systems, adverse-event reports, recalls, warning letters, standard operating procedures, and internal compliance records.

The expert may be asked whether a company followed applicable regulatory requirements, whether a submission accurately characterized a product, whether manufacturing controls were adequate, or whether an alleged regulatory failure is actually related to the injury claimed in litigation.

The correct expert depends heavily on the product involved. A pharmaceutical regulatory specialist may not be the best choice for a medical-device quality-system dispute.

FDA Drug Approval Cases

Drug-development litigation can involve the process leading from clinical investigation to FDA marketing approval.

Expert Institute identifies New Drug Applications, Investigational New Drug applications, Biologics License Applications, and generic drug submissions among the areas addressed by FDA regulatory experts.

A regulatory expert may examine what information was submitted to FDA, whether relevant safety information was communicated, and how the agency evaluated the product.

These cases can be highly technical because the regulatory history may span years of testing, amendments, agency correspondence, and post-approval obligations.

Medical Device FDA Regulation

Medical devices follow different regulatory pathways from pharmaceuticals.

A medical-device regulatory expert may evaluate device classification, 510(k) submissions, premarket approval, clinical testing, quality systems, labeling, manufacturing controls, and postmarket reporting.

Expert Institute specifically identifies 510(k) and PMA issues among the core areas handled by FDA regulations experts.

FDA Labeling Cases

Product labeling can become central in pharmaceutical, medical-device, and other FDA-regulated litigation.

An expert may evaluate whether labeling accurately described indications, contraindications, warnings, instructions, risks, and other required information.

Regulatory affairs experts may also examine the process by which labeling changed over time and the communications between the manufacturer and FDA.

Expert Institute identifies labeling compliance and promotional claims as common FDA regulatory expert issues.

The regulatory expert generally addresses the FDA framework. A physician or pharmacologist may separately address whether an alleged labeling deficiency caused a particular medical injury.

Warning and Failure-to-Warn Cases

A product liability case may allege that a manufacturer should have provided stronger warnings about a drug or device.

An FDA regulations expert may explain what regulatory requirements governed the labeling and what information was available to the agency and manufacturer at relevant points in time.

The expert should distinguish between regulatory compliance and the ultimate legal question of whether a warning was adequate under state law.

The two issues can overlap, but they are not necessarily identical.

Clinical Trial Regulatory Compliance

Clinical trials involving drugs and devices operate within detailed regulatory frameworks.

An expert may evaluate protocol compliance, informed-consent procedures, safety reporting, investigational product handling, monitoring, and documentation.

Expert Institute lists clinical-trial regulatory oversight, INDs, IDEs, and safety reporting among FDA regulatory expert issues.

These cases may also involve clinical research experts, physicians, biostatisticians, or institutional review board specialists depending on the allegation.

Adverse Event Reporting

Manufacturers of certain FDA-regulated products have postmarket reporting obligations.

Litigation may involve whether adverse events were recognized, investigated, and reported appropriately.

A regulatory expert may examine internal complaint files, medical-device reports, pharmacovigilance systems, safety databases, and communications with FDA.

Expert Institute specifically identifies adverse-event and medical-device reporting as a common area of FDA regulatory testimony.

The existence of an adverse event does not itself prove a reporting violation, and a reporting violation does not automatically establish that the event caused the plaintiff's injury.

Good Manufacturing Practice

Manufacturing quality can become a major issue in pharmaceutical and biologics litigation.

An FDA regulatory or quality expert may evaluate current good manufacturing practice requirements, process controls, validation, documentation, contamination controls, corrective actions, and quality oversight.

For medical devices, quality-system requirements may be more relevant than pharmaceutical cGMP provisions.

Expert Institute identifies cGMP and quality-system compliance among the major regulatory issues these experts address.

A manufacturing engineer or pharmaceutical scientist may also be required when the case turns on how a specific defect physically occurred.

FDA Warning Letters and Enforcement

FDA enforcement records can become important evidence in litigation.

A warning letter, inspection observation, recall, or other regulatory action may identify deficiencies involving manufacturing, labeling, promotion, quality systems, or reporting.

A regulatory expert can explain the significance of the agency action and place it in context.

The existence of an FDA enforcement action does not necessarily establish that the same conduct caused a particular plaintiff's injury.

The expert should connect the regulatory issue to the product and event being litigated.

Product Recalls

Drug and device recalls may occur for many reasons, including contamination, manufacturing defects, labeling problems, device malfunctions, or other quality concerns.

A regulatory expert may examine why the recall occurred, which lots or devices were affected, what corrective actions were taken, and whether the plaintiff's product fell within the recall population.

The expert may also determine whether the recall issue is actually consistent with the mechanism of injury being alleged.

A recall can be highly relevant without automatically resolving causation.

Off-Label Promotion

Physicians may use FDA-approved products in ways that differ from an approved indication, but manufacturer promotion is subject to a separate regulatory framework.

Cases sometimes involve allegations that a manufacturer improperly promoted an off-label use.

An FDA regulatory expert may evaluate promotional materials, sales practices, labeling, internal policies, and regulatory history.

These disputes can overlap with pharmaceutical marketing, compliance, and medical-practice issues.

The expert should remain focused on regulatory conduct rather than opining broadly on what physicians were legally permitted to prescribe.

FDA Compliance and Product Liability

FDA compliance can play a significant role in product liability litigation involving drugs and devices.

A company may argue that its product underwent extensive FDA review and complied with applicable requirements.

A plaintiff may allege that important information was omitted, manufacturing controls failed, or postmarket obligations were not followed.

A regulatory expert can explain what FDA actually required and what the regulatory record shows.

That can prevent either side from treating "FDA approved" or "FDA compliant" as a substitute for a detailed analysis.

Regulatory Affairs Expert Versus Medical Expert

An FDA regulatory specialist is not generally the same expert who should diagnose a medical injury.

The regulatory expert may explain approval pathways, labeling, quality systems, reporting requirements, or communications with FDA.

A physician may determine whether the drug or device caused the plaintiff's injury.

A pharmacologist may address drug mechanisms or interactions.

An engineer may evaluate a device failure.

Complex product cases often require multiple experts because regulatory compliance and medical causation are separate questions.

Regulatory Affairs Expert Versus Medical Device Engineer

A regulatory affairs expert focuses on compliance with FDA requirements and the regulatory lifecycle of the device.

A medical device engineer evaluates design, mechanical performance, failure modes, testing, and technical specifications.

A defective implant case, for example, may require a regulatory expert to address FDA submissions and an engineer to determine why the physical component failed.

Regulatory Affairs Expert Versus Pharmacologist

A pharmacologist focuses on how drugs act in the body, including dose-response relationships, metabolism, toxicity, and interactions.

An FDA regulatory expert focuses on the rules governing development, approval, labeling, manufacturing, and postmarket oversight.

A pharmaceutical case may require both.

The regulatory expert can explain what the manufacturer was required to report or disclose, while the pharmacologist evaluates whether the substance could produce the alleged biological effect.

Former FDA Officials as Expert Witnesses

Some of the strongest FDA regulatory experts have worked directly within the agency.

Expert Institute profiles regulatory witnesses with extensive prior FDA field experience as well as senior industry professionals who have managed regulatory submissions, clinical trials, and quality systems.

Former FDA experience can be particularly useful when the dispute requires understanding agency procedures, inspections, review practices, or regulatory correspondence.

Industry regulatory affairs experience may be more important when the case concerns how companies actually implement compliance systems.

Pharmaceutical Regulatory Affairs

Drug and biologics cases may involve the entire regulatory lifecycle from development through postmarketing.

Expert Institute profiles specialists whose regulatory work covers discovery, product development, approval, launch, and postmarket obligations for drugs and biologics.

A pharmaceutical regulatory expert may review clinical development programs, NDA or BLA submissions, labeling, safety reporting, manufacturing changes, and communications with FDA.

This is often distinct from the work of a prescribing physician or general pharmacology expert.

Plaintiff FDA Regulations Expert Witnesses

Plaintiff attorneys may retain an FDA regulations expert to determine whether a manufacturer failed to follow regulatory requirements, omitted important information, inadequately reported safety concerns, improperly promoted a product, or maintained deficient quality systems.

The strongest opinion should identify the specific requirement at issue and explain how the alleged regulatory failure relates to the case.

A general claim that a company "violated FDA rules" is usually less useful than a focused analysis tied to the product and conduct involved.

Defense FDA Regulations Expert Witnesses

Defense attorneys may retain an FDA expert to establish what regulations actually required and whether the manufacturer complied.

The expert may also challenge attempts to characterize guidance, internal policy, inspection observations, or later regulatory actions as binding requirements that existed at the time of the alleged conduct.

Regulatory timing is especially important because FDA rules, guidance, and industry practices can change over the life of a product.

Choosing an FDA Regulations Expert Witness

The strongest expert should match both the regulated product and the specific compliance issue.

A drug-approval case may require someone with pharmaceutical submission experience.

A medical-device case may favor an expert familiar with 510(k), PMA, and device quality systems.

A manufacturing dispute may require deep cGMP experience.

A clinical trial matter may need an expert with IND, IDE, GCP, and safety-reporting expertise.

The closer the expert's professional history is to the regulatory issue in the case, the stronger the fit is likely to be.

Find an FDA Regulations Expert Witness

FDA regulatory cases can involve drugs, biologics, medical devices, clinical trials, labeling, advertising, approval pathways, quality systems, manufacturing practices, adverse-event reporting, recalls, and enforcement actions.

Blackstorm Experts helps attorneys identify FDA regulations expert witnesses whose agency, industry, scientific, and regulatory backgrounds match the particular product and compliance issue involved in the matter.

Send us the regulated product, FDA issue, relevant time period, and opinions that need to be addressed. We can identify former FDA officials, regulatory affairs professionals, pharmaceutical specialists, and medical-device regulatory experts whose experience fits the case.

Start an expert witness search